Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Body Mass Index and Sex Affect Diverse Microbial Niches within the Gut.

Borgo F, Garbossa S, Riva A, Severgnini M, Luigiano C, Benetti A, Pontiroli AE, Morace G, Borghi E.

Front Microbiol. 2018 Feb 14;9:213. doi: 10.3389/fmicb.2018.00213. eCollection 2018.

2.

Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.

De Riva A, Wållberg M, Ronchi F, Coulson R, Sage A, Thorne L, Goodfellow I, McCoy KD, Azuma M, Cooke A, Busch R.

PLoS One. 2017 Aug 3;12(8):e0181964. doi: 10.1371/journal.pone.0181964. eCollection 2017.

3.

Prevalence study on potential drug-drug interaction in cancer patients in Piacenza hospital's Onco-Haematology department.

Vecchia S, Orlandi E, Confalonieri C, Damonti E, Riva A, Sartori A, Cavanna L.

J Oncol Pharm Pract. 2018 Oct;24(7):490-493. doi: 10.1177/1078155217717324. Epub 2017 Jul 16.

PMID:
28714379
4.

Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests.

Borgo F, Riva A, Benetti A, Casiraghi MC, Bertelli S, Garbossa S, Anselmetti S, Scarone S, Pontiroli AE, Morace G, Borghi E.

PLoS One. 2017 Jun 21;12(6):e0179739. doi: 10.1371/journal.pone.0179739. eCollection 2017.

5.

Members of the Oral Microbiota Are Associated with IL-8 Release by Gingival Epithelial Cells in Healthy Individuals.

Schueller K, Riva A, Pfeiffer S, Berry D, Somoza V.

Front Microbiol. 2017 Mar 15;8:416. doi: 10.3389/fmicb.2017.00416. eCollection 2017.

6.

A 12-week intervention with nonivamide, a TRPV1 agonist, prevents a dietary-induced body fat gain and increases peripheral serotonin in moderately overweight subjects.

Hochkogler CM, Lieder B, Rust P, Berry D, Meier SM, Pignitter M, Riva A, Leitinger A, Bruk A, Wagner S, Hans J, Widder S, Ley JP, Krammer GE, Somoza V.

Mol Nutr Food Res. 2017 May;61(5). doi: 10.1002/mnfr.201600731. Epub 2017 Feb 22.

PMID:
28012242
7.

Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.

Riva A, Borgo F, Lassandro C, Verduci E, Morace G, Borghi E, Berry D.

Environ Microbiol. 2017 Jan;19(1):95-105. doi: 10.1111/1462-2920.13463. Epub 2016 Aug 22.

8.

Relative Abundance in Bacterial and Fungal Gut Microbes in Obese Children: A Case Control Study.

Borgo F, Verduci E, Riva A, Lassandro C, Riva E, Morace G, Borghi E.

Child Obes. 2017 Feb;13(1):78-84. doi: 10.1089/chi.2015.0194. Epub 2016 Mar 23.

PMID:
27007700
9.

Methicillin-Resistant Staphylococcus aureus in Raw Milk: Prevalence, SCCmec Typing, Enterotoxin Characterization, and Antimicrobial Resistance Patterns.

Riva A, Borghi E, Cirasola D, Colmegna S, Borgo F, Amato E, Pontello MM, Morace G.

J Food Prot. 2015 Jun;78(6):1142-6. doi: 10.4315/0362-028X.JFP-14-531.

10.

Absence of surrogate light chain results in spontaneous autoreactive germinal centres expanding V(H)81X-expressing B cells.

Grimsholm O, Ren W, Bernardi AI, Chen H, Park G, Camponeschi A, Chen D, Bergmann B, Höök N, Andersson S, Strömberg A, Gjertsson I, Cardell S, Yrlid U, De Riva A, Mårtensson IL.

Nat Commun. 2015 May 11;6:7077. doi: 10.1038/ncomms8077.

PMID:
25959489
11.

Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimens.

Bassi S, Stroppa EM, Moroni CF, Arbasi MC, Trabacchi E, Di Franco A, Lazzaro A, Bernuzzi P, Moretto M, Arcari A, Bosi C, Riva A, Cavanna L, Vallisa D.

Blood Transfus. 2015 Jul;13(3):478-83. doi: 10.2450/2015.0198-14. Epub 2015 Feb 2.

12.

An Anticancer Drug Unit for the whole provincial oncologic network of Piacenza: improving safety and savings.

Mordenti P, Vecchia S, Damonti E, Riva A, Muroni M, Cordani MR, Cremona G, Cavanna L.

Med Oncol. 2015 Feb;32(2):457. doi: 10.1007/s12032-014-0457-y. Epub 2015 Jan 9.

PMID:
25572812
13.

MHC Class II Protein Turnover In vivo and Its Relevance for Autoimmunity in Non-Obese Diabetic Mice.

De Riva A, Busch R.

Front Immunol. 2013 Nov 25;4:399. doi: 10.3389/fimmu.2013.00399. Review.

14.

Accelerated turnover of MHC class II molecules in nonobese diabetic mice is developmentally and environmentally regulated in vivo and dispensable for autoimmunity.

De Riva A, Varley MC, Bluck LJ, Cooke A, Deery MJ, Busch R.

J Immunol. 2013 Jun 15;190(12):5961-71. doi: 10.4049/jimmunol.1300551. Epub 2013 May 15.

15.

On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.

Busch R, De Riva A, Hadjinicolaou AV, Jiang W, Hou T, Mellins ED.

Expert Rev Mol Med. 2012 Jul 6;14:e15. doi: 10.1017/erm.2012.9. Review.

16.

HIV-infected patients and liver transplantation: who, when and why.

Tavio M, Grossi P, Baccarani U, Scudeller L, Pea F, Berretta M, Adani G, Vivarelli M, Riva A, Tirelli U, Bresadola V, Viale P, Risaliti A.

Curr HIV Res. 2011 Mar;9(2):120-7. Review.

PMID:
21222618
17.

Acute liver injury after intravenous amiodarone: a case report.

Verhovez A, Elia F, Riva A, Ferrari G, Aprà F.

Am J Emerg Med. 2011 Sep;29(7):843.e5-6. doi: 10.1016/j.ajem.2010.03.035. Epub 2010 Sep 25.

PMID:
20870371
18.

Measurement of protein synthesis using heavy water labeling and peptide mass spectrometry: Discrimination between major histocompatibility complex allotypes.

De Riva A, Deery MJ, McDonald S, Lund T, Busch R.

Anal Biochem. 2010 Aug;403(1-2):1-12. doi: 10.1016/j.ab.2010.04.018. Epub 2010 Apr 18.

19.

Therapeutic efficacy of buforin II and rifampin in a rat model of Acinetobacter baumannii sepsis.

Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Gabrielli E, Mocchegiani F, Cianforlini N, Trombettoni MM, Saba V, Scalise G, Giacometti A.

Crit Care Med. 2009 Apr;37(4):1403-7. doi: 10.1097/CCM.0b013e31819c3e22.

PMID:
19318826
20.

In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.

Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A, Scalise G.

Med Mycol. 2009 May;47(3):321-6. doi: 10.1080/13693780802641920. Epub 2008 Dec 27.

PMID:
19115137
21.

Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection.

Cirioni O, Silvestri C, Ghiselli R, Orlando F, Riva A, Mocchegiani F, Chiodi L, Castelletti S, Gabrielli E, Saba V, Scalise G, Giacometti A.

J Antimicrob Chemother. 2008 Dec;62(6):1332-8. doi: 10.1093/jac/dkn393. Epub 2008 Sep 16.

PMID:
18799470
22.

Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis.

Cirioni O, Ghiselli R, Silvestri C, Kamysz W, Orlando F, Riva A, Kamysz E, Castelletti S, Rocchi M, Saba V, Scalise G, Giacometti A.

Antimicrob Agents Chemother. 2008 Dec;52(12):4351-5. doi: 10.1128/AAC.00086-08. Epub 2008 Sep 8.

23.

Censoring of autoreactive B cell development by the pre-B cell receptor.

Keenan RA, De Riva A, Corleis B, Hepburn L, Licence S, Winkler TH, Mårtensson IL.

Science. 2008 Aug 1;321(5889):696-9. doi: 10.1126/science.1157533. Epub 2008 Jun 19.

24.

BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection.

Orlando F, Ghiselli R, Cirioni O, Minardi D, Tomasinsig L, Mocchegiani F, Silvestri C, Skerlavaj B, Riva A, Muzzonigro G, Saba V, Scalise G, Zanetti M, Giacometti A.

Peptides. 2008 Jul;29(7):1118-23. doi: 10.1016/j.peptides.2008.03.005. Epub 2008 Mar 14.

PMID:
18430491
25.

Efficacy of LL-37 and granulocyte colony-stimulating factor in a neutropenic murine sepsis due to Pseudomonas aeruginosa.

Cirioni O, Ghiselli R, Tomasinsig L, Orlando F, Silvestri C, Skerlavaj B, Riva A, Rocchi M, Saba V, Zanetti M, Scalise G, Giacometti A.

Shock. 2008 Oct;30(4):443-8. doi: 10.1097/SHK.0b013e31816d2269.

PMID:
18391859
26.

RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus.

Simonetti O, Cirioni O, Ghiselli R, Goteri G, Scalise A, Orlando F, Silvestri C, Riva A, Saba V, Madanahally KD, Offidani A, Balaban N, Scalise G, Giacometti A.

Antimicrob Agents Chemother. 2008 Jun;52(6):2205-11. doi: 10.1128/AAC.01340-07. Epub 2008 Apr 7.

27.

Analyzing stochastic transcription to elucidate the nucleoid's organization.

Riva A, Carpentier AS, Barloy-Hubler F, Chéron A, Hénaut A.

BMC Genomics. 2008 Mar 10;9:125. doi: 10.1186/1471-2164-9-125.

28.

Tachyplesin III and granulocyte-colony stimulating factor enhance the efficacy of tazobactam/piperacillin in a neutropenic mouse model of polymicrobial peritonitis.

Cirioni O, Ghiselli R, Kamysz W, Orlando F, Silvestri C, Mocchegiani F, Di Matteo F, Kamysz E, Riva A, Rocchi M, Saba V, Scalise G, Giacometti A.

Peptides. 2008 Jan;29(1):31-8. Epub 2007 Nov 6.

PMID:
18068869
29.

In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.

Barchiesi F, Giacometti A, Cirioni O, Arzeni D, Silvestri C, Kamysz W, Abbruzzetti A, Riva A, Kamysz E, Scalise G.

Peptides. 2007 Aug;28(8):1509-13. Epub 2007 Jul 17.

PMID:
17698253
30.
31.

Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.

Cirioni O, Ghiselli R, Silvestri C, Kamysz W, Orlando F, Mocchegiani F, Di Matteo F, Riva A, Lukasiak J, Scalise G, Saba V, Giacometti A.

Antimicrob Agents Chemother. 2007 Jun;51(6):2005-10. Epub 2007 Apr 2.

32.

In vitro activities of tachyplesin III against Pseudomonas aeruginosa.

Cirioni O, Giacometti A, Kamysz W, Silvestri C, Riva A, Della Vittoria A, Abbruzzetti A, Lukasiak J, Scalise G.

Peptides. 2007 Apr;28(4):747-51. Epub 2007 Jan 13.

PMID:
17331619
33.

In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci.

Giacometti A, Cirioni O, Riva A, Kamysz W, Silvestri C, Nadolski P, Della Vittoria A, Łukasiak J, Scalise G.

Antimicrob Agents Chemother. 2007 Apr;51(4):1494-6. Epub 2007 Jan 12.

34.

In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa.

Cirioni O, Giacometti A, Silvestri C, Della Vittoria A, Licci A, Riva A, Scalise G.

Antimicrob Agents Chemother. 2006 Nov;50(11):3923-5. Epub 2006 Aug 28.

35.

Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients.

Genovesi S, Pogliani D, Faini A, Valsecchi MG, Riva A, Stefani F, Acquistapace I, Stella A, Bonforte G, DeVecchi A, DeCristofaro V, Buccianti G, Vincenti A.

Am J Kidney Dis. 2005 Nov;46(5):897-902.

PMID:
16253730
36.

Dense taxonomic EST sampling and its applications for molecular systematics of the Coleoptera (beetles).

Hughes J, Longhorn SJ, Papadopoulou A, Theodorides K, de Riva A, Mejia-Chang M, Foster PG, Vogler AP.

Mol Biol Evol. 2006 Feb;23(2):268-78. Epub 2005 Oct 19.

PMID:
16237206
37.

Comments on selected fundamental aspects of microarray analysis.

Riva A, Carpentier AS, Torrésani B, Hénaut A.

Comput Biol Chem. 2005 Oct;29(5):319-36. Epub 2005 Oct 10.

PMID:
16219488
38.

In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.

Giacometti A, Cirioni O, Kamysz W, Silvestri C, Licci A, D'Amato G, Nadolski P, Riva A, Lukasiak J, Scalise G.

Antimicrob Agents Chemother. 2005 Sep;49(9):3933-6.

39.

In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.

Giacometti A, Cirioni O, Kamysz W, D'Amato G, Silvestri C, Licci A, Nadolski P, Riva A, Lukasiak J, Scalise G.

Int J Antimicrob Agents. 2005 Sep;26(3):235-40.

PMID:
16122911
40.

In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.

Giacometti A, Cirioni O, Kamysz W, D'Amato G, Silvestri C, Del Prete MS, Licci A, Riva A, Lukasiak J, Scalise G.

Antimicrob Agents Chemother. 2005 Mar;49(3):1249-52.

41.

Characterization of the GATC regulatory network in E. coli.

Riva A, Delorme MO, Chevalier T, Guilhot N, Hénaut C, Hénaut A.

BMC Genomics. 2004 Jul 20;5(1):48.

42.

The difficult interpretation of transcriptome data: the case of the GATC regulatory network.

Riva A, Delorme MO, Chevalier T, Guilhot N, Hénaut C, Hénaut A.

Comput Biol Chem. 2004 Apr;28(2):109-18.

PMID:
15130539
43.

The operons, a criterion to compare the reliability of transcriptome analysis tools: ICA is more reliable than ANOVA, PLS and PCA.

Carpentier AS, Riva A, Tisseur P, Didier G, Hénaut A.

Comput Biol Chem. 2004 Feb;28(1):3-10.

PMID:
15022635
44.

Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.

Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Riva A, Del Prete MS, Saba V, Scalise G.

Antimicrob Agents Chemother. 2002 Sep;46(9):2885-8.

Supplemental Content

Loading ...
Support Center